Advertisement

A study conducted by researchers from Brigham and Women’s Hospital in Boston shows that taking cholesterol-lowering drugs in the statin family is linked to reduced diagnoses of prostate cancer.

The researchers analyzed the electronic and paper-based data of more than 55,000 men from the Veteran Affairs New England Healthcare System who were taking either a statin or an anti-hypertension medication. Those men on statins were found to be 60 percent less likely to be diagnosed with high-grade prostate tumors.

SOURCE

Advertisement
Advertisement